Blood and marrow transplantation activity in Europe 1996

Bone Marrow Transplantation

Volumn 22, Issue 3, 1998, Pages 227-240

  Gratwohl, A ^a   Passweg, J ^a   Baldomero, H ^a   Hermans, J ^b  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b LEIDEN UNIVERSITY   (Netherlands)

Author keywords

Bone marrow transplantation; Coefficient of variation; Epidemiology; Europe; Peripheral blood stem cell transplantation; Transplant activity

Indexed keywords

ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BONE MARROW TRANSPLANTATION; BREAST CARCINOMA; EUROPE; HEALTH CARE PLANNING; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; INCIDENCE; LEUKEMIA; LYMPHOMA; MAJOR CLINICAL STUDY; MULTIPLE MYELOMA; PATIENT COUNSELING; PRIORITY JOURNAL; SOLID TUMOR;

EID: 0031858426     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1701329     Document Type: Article

References (37)

1. Gathi RA, Meuwissen HJ, Allen HD et al. Immunologic reconstitution of sex-linked lymphopenic immunological deficiency. Lancet 1968; ii: 1366-1369.
2. Bach FH, Albertini RJ, Joo P et al. Bone marrow transplantation in a patient with Wiskott Aldrich syndrome. Lancet 1968; ii: 1364-1366.
3. Forman SJ, Blume KG, Thomas ED (eds). Bone Marrow Transplantation. Blackwell: Oxford, 1994.
4. Armitage JO. Bone marrow transplantation. New Engl J Med 1994; 330: 827-838.
5. Rowe JM, Ciobanu N, Ascensao J et al. Recommended guidelines for the management of autologous and allogeneic bone marrow transplantation. Ann Intern Med 1994; 120: 143-158.
6. Schmitz N, Gratwohl A, Goldman JM. Special report: allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders. Current practice in Europe in 1996 and proposals for an operational classification. Bone Marrow Transplant 1996; 17: 471-477.
7. Bortin MM, Rimm AA. Increasing utilization of bone marrow transplantation. Transplantation 1986: 42: 223-234.
8. Bortin MM, Rimm AA. Increasing utilization of bone marrow transplantation. Results of the 1985-1987 survey. Transplantation 1989; 48: 453-458.
9. Gratwohl A. Bone marrow transplantation activity in Europe 1990. Report from the European Group for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant 1991; 8: 197-201.
10. Gratwohl A, Hermans J, Goldman J, Gahrton G. Bone marrow transplantation in Europe. Major geographical differences. J Int Med 1993; 233: 333-341.
11. Gratwohl A, Hermans J. Bone marrow transplantation activity in Europe 1992. Report from the European Group for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant 1994; 13: 5-10.
12. Gratwohl A, Hermans J. Indications and donor source of hematopoietic stem cell transplants in Europe 1993. Clin Transplant 1995; 9: 355-363.
13. Gratwohl A, Hermans J, Baldomero H. Hematopoietic precursor cell transplants in Europe: activity in 1994. Report from the European Group for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant 1996; 17: 137-148.
14. Gratwohl A. Special report. A report from the President and the Chairmen of the Working Parties of the European Group for Blood and Marrow Transplantation (EBMT): Bone Marrow Transplant 1996; 18: 677-681.
15. Fischers Weltalmanach 1996. Fischer Taschenbuchverlag GmbH, Frankfurt am Main.
16. Kirkwood BR (ed). Essentials of Medical Statistics. Blackwell Scientific Publication: Oxford, 1991.
17. Gratwohl A, Baldomero H, Hermans J. Quantitative assessment of consensus on indications for blood or marrow transplantation in Europe 1995. Cancer Res Ther Control (in press).
18. Attal M, Harousseau JL, Stoppa AM et al. A prospective randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. New Engl J Med 1996; 335: 91-97.
19. Zittoun R, Mandelli F, Willemze R et al. Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. New Engl J Med 1993; 332: 217-223.
20. Philip T, Guglielmi C, Hagenbeek A et al. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy sensitive non-Hodgkin's lymphoma. New Engl J Med 1995; 333: 1540-1545.
21. Kolb HJ, Schattenberg A, Goldman JM et al. Graft-versusleukemia effect of donor lymphocyte transfusions in marrow grafted patients for the European Group for Blood and Marrow Transplantation (EBMT) Working Party Chronic Leukemia. Blood 1995; 86: 2041-2050.
22. Franklin IM. Letter to the Editor: Consensus conference on unrelated donor bone marrow transplantation: Royal College of Physicians of Edinburgh, October 29th and 30th, 1996. Blood 1997; 89: 2226-2228.
23. Kurtzberg J, Laughlin M, Graham ML et al. Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. New Engl J Med 1996; 335: 157-166.
24. Laporte J-P, Gorin N-C, Rubinstein P et al. Cord-blood transplantation from an unrelated donor in an adult with chronic myelogeneous leukemia. New Engl J Med 1996; 335 167-170.
25. Gluckman E, Rocha V, Boyer-Chammard A et al. Outcome of cord-blood transplantation from related and unrelated donors. New Engl J Med 1997; 337: 373-381.
26. Schmitz N, Bacigalupo A, Labopin M et al for the European Group for Blood and Marrow Transplantation (EBMT). Transplantation of peripheral blood progenitor cells from HLA-identical sibling donors. Br J Haematol 1996; 95: 715-723.
27. Goldman JM. Peripheral blood stem cells for allografting. Blood 1995; 85: 1413-1416.
28. Bensinger WI, Weaver CH, Appelbaurn FR et al. Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony stimulating factor. Blood 1995; 85: 1655-1658.
29. Schmitz N, Dryer P, Suttorp M et al. Primary transplantation of allogeneic peripheral blood progenitor cells mobilised by filgrastim. Blood 1990; 85: 1616-1617.
30. Körbling M, Przepiorka D, Huh YO et al. Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: potential advantage of blood over marrow allografts. Blood 1995; 85:1659-1665.
31. Schmitz N, Bacigalupo A, Labopin M et al for the European Group for Blood and Marrow Transplantation (EBMT). Transplantation of peripheral blood progenitor cells from HLA-identical sibling donors. Br J Haematol 1996; 95: 715-723.
32. Schmitz N, Bacigalupo A, Hasenclever D et al. Allogeneic bone marrow transplantation versus filgrastim-mobilized peripheral blood progenitor cell transplantation in patienls with early leukemia. Bone Marrow Transplant (in press).
33. Anderlini P, Körbling M, Dale D et al. Allogeneic blood stem cell transplantation: considerations for donors. Blood 1997; 90: 903-908.
34. Rosti G, Philip T, Chauvin F et al for the EBMT Solid Tumor Working Party. European Group for Blood and Marrow Transplantation Registry in solid tumours: 13 years of experience. Bone Marrow Transplant 1997; 19 (Suppl. 1): S86.
35. Tyndall A, Gratwohl A. Blood and marrow stem cell transplants in auto-immune disease: a consensus report written on behalf of the European league against Rheumatism (EULAR) and the European Group for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant 1997; 19: 643-645.
36. Snowden JA, Biggs JC, Brooks PM. Autologous blood stem cell transplantation for autoimmune diseases. Lancet 1996; 348: 1112-1113.
37. Jensen OM, Esteve J, Moller H et al. Cancer in the European Community and its member states. Eur J Cancer 1990; 26: 1167-1256.